{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:27:59Z","timestamp":1781717279856,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12640-019-00112-z","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T10:02:47Z","timestamp":1578477767000},"page":"753-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study"],"prefix":"10.1007","volume":"37","author":[{"given":"Hussein Kadhem","family":"Al-Hakeim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas F.","family":"Almulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"112_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2015.04.044","volume":"182","author":"HK Al-Hakeim","year":"2015","unstructured":"Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH (2015) IL-6, IL-18, sIL-2R, and TNF\u03b1 proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord 182:106\u2013114","journal-title":"J Affect Disord"},{"issue":"11","key":"112_CR2","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1007\/s12035-019-01647-0","volume":"56","author":"Hussein Kadhem Al-Hakeim","year":"2019","unstructured":"Al-Hakeim HK, Al-Fadhel SZ, Al-Dujaili AH, Carvalho A, Sriswasdi S, Maes M (2019) Development of a novel neuro-immune and opioid-associated fingerprint with a cross-validated ability to identify and authenticate unknown patients with major depression: far beyond differentiation, discrimination, and classification. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-019-01647-0","journal-title":"Molecular Neurobiology"},{"key":"112_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pnpbp.2012.06.014","volume":"42","author":"G Anderson","year":"2013","unstructured":"Anderson G, Maes M (2013) Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuro-Psychopharmacol Biol Psychiatry 42:5\u201319","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"112_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"7","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Brit J Psychiatry Suppl 7:49\u201358","journal-title":"Brit J Psychiatry Suppl"},{"issue":"Suppl 1","key":"112_CR5","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/ard.59.suppl_1.i60","volume":"59","author":"WP Arend","year":"2000","unstructured":"Arend WP, Guthridge CJ (2000) Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 59(Suppl 1):i60\u2013i64","journal-title":"Ann Rheum Dis"},{"key":"112_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289\u2013300","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"112_CR7","first-page":"91","volume":"3","author":"BM Bettcher","year":"2016","unstructured":"Bettcher BM, Fitch R, Wynn MJ, Lalli MA, Elofson J, Jastrzab L, Mitic L, Miller ZA et al (2016) MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer\u2019s disease dementia phenotypes. Alzheimer\u2019s Dement Diagnosis. Assess Dis Monit 3:91\u201397","journal-title":"Assess Dis Monit"},{"issue":"1","key":"112_CR8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","volume":"14","author":"D Boerrigter","year":"2017","unstructured":"Boerrigter D, Weickert TW, Lenroot R, O\u2019Donnell M, Galletly C, Liu D, Burgess M, Cadiz R et al (2017) Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation 14(1):188","journal-title":"J Neuroinflammation"},{"key":"112_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2017.03.038","volume":"253","author":"KM Boll","year":"2017","unstructured":"Boll KM, Noto C, Bonif\u00e1cio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG (2017) Oxidative and nitrosative stress biomarkers in chronic schizophrenia. Psychiatry Res 253:43\u201348","journal-title":"Psychiatry Res"},{"key":"112_CR10","first-page":"91","volume-title":"Methods in molecular medicine, vol. 36: septic shock","author":"MG Bouma","year":"1999","unstructured":"Bouma MG, Buurman WA (1999) Assay of soluble tumor necrosis factor receptors. In: Evans TJ (ed) Methods in molecular medicine, vol. 36: septic shock. Humana Press, Totowa, NJ, pp 91\u2013100"},{"issue":"suppl-1","key":"112_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/geroni\/igx004.2084","volume":"1","author":"L Butcher","year":"2017","unstructured":"Butcher L, Peres K, Andre P, Walter S, Dartigues J, Rodriguez-Manas L, Feart C, Erusalimsky JD (2017) Cognitive status is associated with CCL11 in older rural dwellers: findings from the FRAILOMIC study. Innov Aging 1(suppl-1):595","journal-title":"Innov Aging"},{"key":"112_CR12","unstructured":"CAMO (2019) The Unscrambler appendices: method references. 2019. Accessed 19 March 2019. www.camo.com\/helpdocs\/The_Unscrambler_Method_References.pdf"},{"key":"112_CR13","first-page":"173","volume-title":"Chapter 9. Partial least squares structural equation modeling: basic concepts, methodological issues and applications","author":"GA Cepeda-Carrion","year":"2018","unstructured":"Cepeda-Carrion GA, Nitzl C, Roldan JL (2018) Mediation analyses in partial least squares structural equation modeling: guidelines and empirical examples. In: Latan H, Noonan R (eds) Chapter 9. Partial least squares structural equation modeling: basic concepts, methodological issues and applications. Springer, Heidelberg, pp 173\u2013195"},{"key":"112_CR14","doi-asserted-by":"crossref","first-page":"39327","DOI":"10.1074\/jbc.M111841200","volume":"277","author":"S Dasgupta","year":"2002","unstructured":"Dasgupta S, Jana M, Liu X, Pahan K (2002) Myelin basic protein-primed T cells induced nitric oxide synthase in microglial cells. Implications for multiple sclerosis. J Biol Chem 277:39327\u201339333","journal-title":"J Biol Chem"},{"key":"112_CR15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0004867414533012","volume":"48","author":"J Davis","year":"2014","unstructured":"Davis J, Moylan S, Harvey BH, Maes M, Berk M (2014) Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries. Aust NZ J Psychiatry 48:512\u2013529","journal-title":"Aust NZ J Psychiatry"},{"key":"112_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","volume":"65","author":"J Davis","year":"2016","unstructured":"Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, McGorry PD, Pantelis C, Berk M (2016) A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185\u2013194","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"112_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.114.213074","volume":"349","author":"MA Erickson","year":"2014","unstructured":"Erickson MA, Morofuji Y, Owen JB, Banks WA (2014) Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther 349(3):497\u2013507","journal-title":"J Pharmacol Exp Ther"},{"key":"112_CR18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839\u2013855","journal-title":"Nat Rev Neurosci"},{"key":"112_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","volume":"71","author":"D Frydecka","year":"2018","unstructured":"Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Sta\u0144czykiewicz B, Besz\u0142ej JA, Piotrowski P, Kotowicz K, Szewczuk-Bogus\u0142awska M, Pawlak-Adamska E, Misiak B (2018) Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study. Brain Behav Immun 71:28\u201336","journal-title":"Brain Behav Immun"},{"issue":"6","key":"112_CR20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S1734-1140(12)70943-X","volume":"64","author":"A G\u0105dek-Michalska","year":"2012","unstructured":"G\u0105dek-Michalska A, Tadeusz J, Rachwalska P, Spyrka J, Bugajski J (2012) Brain nitric oxide synthases in the interleukin-1\u03b2-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol Rep 64(6):1455\u20131465","journal-title":"Pharmacol Rep"},{"issue":"3","key":"112_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004032-198103000-00012","volume":"40","author":"RO Gilbert","year":"1981","unstructured":"Gilbert RO, Kinnison RR (1981) Statistical methods for estimating the mean and variance from radionuclide data sets containing negative, unreported or less-than values. Health Phys 40(3):377\u2013390","journal-title":"Health Phys"},{"issue":"12","key":"112_CR22","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696\u20131709","journal-title":"Mol Psychiatry"},{"key":"112_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)90005-1","volume":"55","author":"EG Gutierrez","year":"1994","unstructured":"Gutierrez EG, Banks WA, Kastin AJ (1994) Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol 55:135\u2013160","journal-title":"J Neuroimmunol"},{"key":"112_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"112_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2016.09.011","volume":"59","author":"E Hennessy","year":"2017","unstructured":"Hennessy E, Gormley S, Lopez-Rodriguez AB, Murray C, Murray C, Cunningham C (2017) Systemic TNF-\u03b1 produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration. Brain Behav Immun 59:233\u2013244","journal-title":"Brain Behav Immun"},{"key":"112_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2016.09.019","volume":"181","author":"S Hong","year":"2017","unstructured":"Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV (2017) Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res 181:63\u201369","journal-title":"Schizophr Res"},{"issue":"7","key":"112_CR27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","volume":"11","author":"S Hope","year":"2009","unstructured":"Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009) Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 11(7):726\u2013734","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"112_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2012.12.023","volume":"145","author":"S Hope","year":"2013","unstructured":"Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P, Andreassen OA (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145(1\u20133):36\u201342","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"112_CR29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2015.04.004","volume":"165","author":"S Hope","year":"2015","unstructured":"Hope S, Hoseth E, Dieset I, Morch RH, Aas M, Aukrus P, Djurovic S, Melle I et al (2015) Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res 165(2\u20133):188\u2013194","journal-title":"Schizophr Res"},{"issue":"1","key":"112_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/acps.12467","volume":"133","author":"EZ Hoseth","year":"2016","unstructured":"Hoseth EZ, Westlye LT, Hope S, Dieset I, Aukrust P, Melle I, Haukvik UK, Agartz I, Ueland T, Ueland T, Andreassen OA (2016) Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls. Acta Psychiatr Scand 133(1):53\u201362","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"112_CR31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","volume":"50","author":"HT Idriss","year":"2000","unstructured":"Idriss HT, Naismith JH (2000) TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50(3):184\u2013195","journal-title":"Microsc Res Tech"},{"issue":"6","key":"112_CR32","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1007\/s12035-017-0751-8","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Hemrungrojn S, Thika S, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2018a) Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia. Mol Neurobiol 55(6):5184\u20135201","journal-title":"Mol Neurobiol"},{"issue":"3","key":"112_CR33","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s12035-017-0465-y","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2018b) Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation. Mol Neurobiol 55(3):2214\u20132226","journal-title":"Mol Neurobiol"},{"issue":"4","key":"112_CR34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11011-018-0208-4","volume":"33","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sriswasdi S, Thika S, Sirivichayakul S, Carvalho AF, Geffard M, Kubera M, Maes M (2018c) Deficit schizophrenia is a discrete diagnostic category defined by neuroimmune and neurocognitive features: results of supervised machine learning. Metab Brain Dis 33(4):1053\u20131067","journal-title":"Metab Brain Dis"},{"issue":"4","key":"112_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jep.12945","volume":"24","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sriswasdi S, Thika S, Stoyanov D, Sirivichayakul S, Carvalho AF, Geffard M, Maes M (2018d) Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis. J Eval Clin Pract 24(4):879\u2013891","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"112_CR36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12640-017-9860-4","volume":"33","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Thika S, Sirivichayakul S, Carvalho AF, Geffard M, Maes M (2018e) In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: a multivariate and machine learning study. Neurotox Res 33(3):621\u2013633","journal-title":"Neurotox Res"},{"key":"112_CR37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"112_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RSE Keefe","year":"2004","unstructured":"Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L (2004) The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68:283\u2013297","journal-title":"Schizophr Res"},{"key":"112_CR39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119\u2013123","journal-title":"Psychiatry Res"},{"issue":"7","key":"112_CR40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ijnp\/pyy013","volume":"21","author":"N Kudo","year":"2018","unstructured":"Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R (2018) Plasma levels of soluble tumor necrosis factor receptor 2 (sTNFR2) are associated with hippocampal volume and cognitive performance in patients with schizophrenia. Int J Neuropsychopharmacol 21(7):631\u2013639","journal-title":"Int J Neuropsychopharmacol"},{"key":"112_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jagp.2016.09.009","volume":"25","author":"EE Lee","year":"2017","unstructured":"Lee EE, Hong S, Martin AS, Eyler LT, Jeste DV (2017) Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry 25:50\u201361","journal-title":"Am J Geriatr Psychiatry"},{"key":"112_CR42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","volume":"71","author":"Y Levkovitz","year":"2010","unstructured":"Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S (2010) A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71:138\u2013149","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"112_CR43","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","volume":"55","author":"M Maes","year":"2018","unstructured":"Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55(12):8885\u20138903","journal-title":"Mol Neurobiol"},{"issue":"2\u20133","key":"112_CR44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","volume":"196","author":"M Maes","year":"2012","unstructured":"Maes M, Rief W (2012) Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res 196(2\u20133):243\u2013249","journal-title":"Psychiatry Res"},{"issue":"1","key":"112_CR45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-1781(90)90057-C","volume":"34","author":"M Maes","year":"1990","unstructured":"Maes M, Schotte C, Maes L, Cosyns P (1990) Clinical subtypes of unipolar depression: part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups. Psychiatry Res 34(1):43\u201357","journal-title":"Psychiatry Res"},{"issue":"1","key":"112_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B, Raus J (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22(1):45\u201353","journal-title":"Psychol Med"},{"issue":"5","key":"112_CR47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89(5):346\u2013351","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"112_CR48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(96)00029-1","volume":"21","author":"M Maes","year":"1996","unstructured":"Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, Berghmans R, Stans G, Desnyder R (1996) Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res 21(1):39\u201350","journal-title":"Schizophr Res"},{"issue":"1","key":"112_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharp\u00e9 S (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1\u201311","journal-title":"Psychiatry Res"},{"issue":"3","key":"112_CR50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","volume":"54","author":"M Maes","year":"2002","unstructured":"Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Altamura CA (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54(3):281\u2013291","journal-title":"Schizophr Res"},{"issue":"11","key":"112_CR51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","volume":"16","author":"M Maes","year":"2012","unstructured":"Maes M, Song C, Yirmiya R (2012a) Targeting IL-1 in depression. Expert Opin Ther Targets 16(11):1097\u20131112","journal-title":"Expert Opin Ther Targets"},{"issue":"2\u20133","key":"112_CR52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.psychres.2012.03.031","volume":"200","author":"M Maes","year":"2012","unstructured":"Maes M, Twisk FN, Johnson C (2012b) Myalgic encephalomyelitis (ME), chronic fatigue yndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res 200(2\u20133):754\u2013760","journal-title":"Psychiatry Res"},{"key":"112_CR53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14728222.2014.888417","volume":"18","author":"M Maes","year":"2014","unstructured":"Maes M, Anderson G, Kubera M, Berk M (2014) Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets 18:495\u2013512","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"112_CR54","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.20944\/preprints201812.0092.v1","volume":"56","author":"M Maes","year":"2018","unstructured":"Maes M, Brum MJ, Congio A, Bonifacio K, Barbosa D, Vargas H, Michelin A, Carvalho AF et al (2018) Development of a novel staging model for affective disorders using partial least squares bootstrapping: effects of lipid-associated antioxidant defenses and neuro-oxidative stress. Mol Neurobiol 56(9):6626\u20136644. https:\/\/doi.org\/10.20944\/preprints201812.0092.v1","journal-title":"Mol Neurobiol"},{"key":"112_CR55","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1007\/s12035-018-1437-6","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019a) In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome. Mol Neurobiol 56:5122\u20135135","journal-title":"Mol Neurobiol"},{"issue":"3","key":"112_CR56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12640-018-9987-y","volume":"35","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019b) In schizophrenia, increased plasma IgM\/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype. Neurotox Res 35(3):684\u2013698","journal-title":"Neurotox Res"},{"key":"112_CR57","doi-asserted-by":"publisher","unstructured":"Maes, M, Sirivichayakul, S, Kanchanatawan, B, Carvalho AF. (2019c) In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde. Preprints, 2019-010108. doi: https:\/\/doi.org\/10.20944\/preprints201901.0108.v1","DOI":"10.20944\/preprints201901.0108.v1"},{"key":"112_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12640-019-00054-6","volume":"36","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019d) Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia. Neurotox Res 36:306\u2013322. https:\/\/doi.org\/10.1007\/s12640-019-00054-6","journal-title":"Neurotox Res"},{"key":"112_CR59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663\u2013671","journal-title":"Biol Psychiatry"},{"issue":"4","key":"112_CR60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/acps.12783","volume":"136","author":"RH Morch","year":"2017","unstructured":"Morch RH, Dieset I, Faerden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Haram M et al (2017) Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study. Acta Psychiatr Scand 136(4):400\u2013408","journal-title":"Acta Psychiatr Scand"},{"key":"112_CR61","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris G, Berk M, Galecki P, Walder K, Maes M (2016) The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol 53:1195\u20131219","journal-title":"Mol Neurobiol"},{"key":"112_CR62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E et al (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry 16:422\u2013429","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"112_CR63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA, Cordeiro Q, Belangero SI, Gadelha A, Bressan RA, Noto C (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29(3):416\u2013431","journal-title":"Eur Neuropsychopharmacol"},{"key":"112_CR64","unstructured":"OLink Proteomics (2019) How is the limit of detection (LOD) estimated and how is this handled in the data analysis? Accessed 4 Sept 2019. https:\/\/www.olink.com\/question\/how-is-the-limit-of-detection-lod-estimated-and-handled\/"},{"key":"112_CR65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"issue":"6","key":"112_CR66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.smim.2013.10.007","volume":"5","author":"P Piccioli","year":"2013","unstructured":"Piccioli P, Rubartelli A (2013) The secretion of IL-1\u03b2 and options for release. Semin Immunol 5(6):425\u2013429","journal-title":"Semin Immunol"},{"issue":"8","key":"112_CR67","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/es00173a001","volume":"22","author":"PS Porter","year":"1988","unstructured":"Porter PS, Ward RC, Bell HF (1988) The detection limit. Environ Sci Technol 22(8):856\u2013861","journal-title":"Environ Sci Technol"},{"issue":"8","key":"112_CR68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63(8):801\u2013808","journal-title":"Biol Psychiatry"},{"key":"112_CR69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0361-9230(92)90033-T","volume":"29","author":"JK Relton","year":"1992","unstructured":"Relton JK, Rothwell NJ (1992) Interleukin-1 receptor antagonist inhibits ischemic and excitatory neuronal damage in the rat. Brain Res Bull 29:243\u2013246","journal-title":"Brain Res Bull"},{"key":"112_CR70","volume-title":"SmartPLS 3","author":"CM Ringle","year":"2015","unstructured":"Ringle CM, Wende S, Becker J-M (2015) SmartPLS 3. SmartPLS, B\u00f6nningstedt Retrieved from http:\/\/www.smartpls.com. Accessed 11 May 2019"},{"key":"112_CR71","doi-asserted-by":"publisher","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M. (2019) The role of aberrations in the immune-inflammatory reflex system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Preprints 2018, 2018090289, doi: https:\/\/doi.org\/10.20944\/preprints201809.0289.v1. Mol Neurobiol","DOI":"10.20944\/preprints201809.0289.v1"},{"issue":"1","key":"112_CR72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2567.1998.00481.x","volume":"94","author":"CL Selinsky","year":"1998","unstructured":"Selinsky CL, Boroughs KL, Halsey WA, Howell MD (1998) Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I. Immunology 94(1):88\u201393","journal-title":"Immunology"},{"key":"112_CR73","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84851-8","volume-title":"The neuroimmunological basis of behavior and mental disorders","author":"A Siegel","year":"2009","unstructured":"Siegel A, Zalcman SS (2009) The neuroimmunological basis of behavior and mental disorders. Springer, New York"},{"issue":"2","key":"112_CR74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1871527317666181119115532","volume":"18","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019a) A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions. CNS Neurol Disord Drug Targets 18(2):124\u2013140","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"112_CR75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019b) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35(1):122\u2013138","journal-title":"Neurotox Res"},{"issue":"2","key":"112_CR76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","volume":"45","author":"RS Smith","year":"1995","unstructured":"Smith RS, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45(2):135\u2013141","journal-title":"Med Hypotheses"},{"issue":"3","key":"112_CR77","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2753.2012.01844.x","volume":"18","author":"D Stoyanov","year":"2012","unstructured":"Stoyanov D, Machamer PK, Schaffner KF, Rivera-Hernandez R (2012) The challenge of psychiatric nosology and diagnosis. J Eval Clin Pract 18(3):704\u2013709","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"112_CR78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1529-0131(199801)41:1<139::AID-ART17>3.0.CO;2-T","volume":"41","author":"X Su","year":"1998","unstructured":"Su X, Zhou T, Yang P, Edwards CK, Mountz JD (1998) Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41(1):139\u2013149","journal-title":"Arthritis Rheum"},{"issue":"3","key":"112_CR79","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pnpbp.2007.11.019","volume":"32","author":"AL Teixeira","year":"2008","unstructured":"Teixeira AL, Reis HJ, Nicolato R, Brito-Melo G, Correa H, Teixeira MM, Romano-Silva MA (2008) Increased serum levels of CCL11\/eotaxin in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):710\u2013714","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"112_CR80","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00406-017-0782-1","volume":"267","author":"NA Uranova","year":"2017","unstructured":"Uranova NA, Bonartsev PD, Androsova LV, Rakhmanova VI, Kaleda VG (2017) Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1\u03b2 production. Eur Arch Psychiatry Clin Neurosci 267(5):417\u2013426","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"7362","key":"112_CR81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despr\u00e9s S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477(7362):90\u201394","journal-title":"Nature"},{"issue":"11","key":"112_CR82","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00500-009-0535-9","volume":"14","author":"Wen Wen","year":"2009","unstructured":"Wen W, Hao Z, Yang X (2010) Robust least squares support vector machine based on recursive outlier elimination. Soft Comput 14(11):1241\u20131251","journal-title":"Soft Computing"},{"issue":"6","key":"112_CR83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jnc.12263","volume":"125","author":"L Ye","year":"2013","unstructured":"Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, Qian G, Zheng JC (2013) IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem 125(6):897\u2013908","journal-title":"J Neurochem"},{"key":"112_CR84","volume-title":"International perspectives in philosophy and psychiatry","author":"P Zachar","year":"2014","unstructured":"Zachar P, Stoyanov DS, Aragona M, Jablensky A (2014) Alternative perspectives on psychiatric validation: DSM, ICD, RDoC, and beyond. In: International perspectives in philosophy and psychiatry. Oxford University Press, Oxford"},{"issue":"1","key":"112_CR85","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, Lu D, Wei W, Wang Y, Li H, Fu Y, Zhu L (2019) Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 9(1):5790","journal-title":"Sci Rep"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00112-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T21:25:44Z","timestamp":1722288344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00112-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00112-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"4 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to international and Iraq ethics and privacy laws. Approval for the study was obtained from the Institutional Review Board of the University of Kufa (347\/2019), which is in compliance with the International Guidelines for Human Research protection as required by the Declaration of Helsinki, The Belmont Report, Council for International Organizations of Medical Sciences (CIOMS) Guideline, and International Conference on Harmonization on Good Clinical Practice (ICH-GCP).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}